NewAmsterdam Pharma is a biopharmaceutical company focused on developing treatments for metabolic diseases, particularly cardiovascular disease
NewAmsterdam Pharma is a biopharmaceutical company focused on developing treatments for metabolic diseases, particularly cardiovascular disease. It investigates obicetrapib for lowering LDL cholesterol.